Sorrento Therapeutics, Inc.
SRNE
SRNE was delisted on the 22nd of February, 2023.
68 hedge funds and large institutions have $71.1M invested in Sorrento Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 9 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
30% more call options, than puts
Call options by funds: $57K | Put options by funds: $44K
25% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 16
10% more funds holding
Funds holding: 62 → 68 (+6)
29% less capital invested
Capital invested by funds: $101M → $71.1M (-$29.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.49M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$888K |
| 3 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$854K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$681K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$651K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$1.41M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.27M |
| 3 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$1.26M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$1.01M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$452K |
SRNE Hedge Fund Activity: Q4 2016 in Review
68 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Sorrento Therapeutics, Inc. (SRNE) for Q4 2016, worth a combined $71.1M — down 29% from $101M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new SRNE positions and 9 closed out — a net gain of 6 holders — while 20 added to existing stakes and 16 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $1.49M. The largest seller was C WorldWide Group, exiting entirely with an estimated $1.41M sold.
- 68 institutional investors held Sorrento Therapeutics, Inc. (SRNE) as of Q4 2016, up from 62 in Q3 2016.
- Funds reported $71.1M of Sorrento Therapeutics, Inc. stock for Q4 2016, down 29% quarter-over-quarter.
- 15 funds opened new Sorrento Therapeutics, Inc. positions in Q4 2016 and 9 closed out, a net change of +6 holders.
- The largest Sorrento Therapeutics, Inc. buyer in Q4 2016 was Millennium Management, an estimated $1.49M added.
- The largest Sorrento Therapeutics, Inc. seller in Q4 2016 was C WorldWide Group, an estimated $1.41M sold.
Based on aggregated 13F filings for Q4 2016.